Business Wire

VALAMIS

22.7.2021 10:02:14 CEST | Business Wire | Press release

Share
Valamis Announces Acquisition of The Working Manager to Redefine Internal Career Development

Valamis , the global leader in digital learning technologies and workforce development, has announced the acquisition of The Working Manager (TWM), a leader in organisational performance and career mobility technology. Valamis and TWM have entered into a definitive agreement to join together and unify technologies and in-house consulting services to offer businesses an end-to-end employee experience that helps employees develop and find career opportunities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210722005023/en/

Valamis Learning Solution and TWM’s CareerBurst career platform and learning platform technologies will bring Executives, Human Resources, Learning & Development, and Talent professionals a technology and consulting solution to develop and retain employees for organisational performance. Valamis and TWM will be able to help over 3 million learners and serve a diverse global client base.

“The Working Manager’s technology, proven record of customer satisfaction, and most importantly their people, are a complete fit with Valamis’ longstanding values. With TWM’s internal career development platform, LMS, and LXP, we will enhance our current learning solutions for our customers and future customers. Together, our technology, partnership approach, and authenticity will give the market a solution that puts people first and helps customers every step of the way succeed with their business initiatives”, explained Jussi Hurskainen, CEO, Valamis.

After a long period of remote work for many employees across the world at the onset of the pandemic, many businesses have begun outlining their ‘return to the office’ plans, which has ushered in what NPR is calling the ‘Great Resignation’, as more workers in the U.S. are quitting their jobs than at any time in at least two decades. According to a LinkedIn report , 94% of employees would stay at a company longer if it invested in their careers. The acquisition and combined products and services of Valamis and TWM will provide an opportunity for employers to reduce the high cost of employee turnover and labour shortages by upskilling their employees and improving career mobility.

“At TWM our accounts managers are all former heads of L&D, we understand first-hand many of the challenges that our customers are facing. That helps us develop our software in line with those requirements but also gives us an understanding of the partnership that is required to address the rapidly changing needs of businesses. Valamis has a similar approach and company culture that will empower businesses across the U.K. and globally to build greater employee loyalty and, in the end – stronger businesses”, said Phil Purver, CEO, TWM.

About Valamis

Valamis is an international technology company specialising in cloud-based digital learning solutions that empower millions of learners, companies, and societies to solve their challenges with transformative learning experiences. Valamis’ end-to-end learning solution includes Valamis’ LXP, LMS, LRS, Content Authoring Lesson Studio, eCommerce, and extensive integrations. Valamis creates long-term value for businesses and their people by being a strategic partner in learning while providing technology and consultancy services in design, data science, technology, corporate performance, and digital learning. Founded in 2003, Valamis is headquartered in Finland and maintains offices in countries around the world.

Learn more about Valamis: Website | YouTube | LinkedIn | Twitter

About TWM

TWM is the most reputable provider of Learning Platforms for clients who have a strategic take on developing their people. Our difference is that our people are former L&D professionals. We always work closely and in partnership with clients, helping solve their problems and providing a platform that we guarantee will do what we say it will.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye